Home » Stocks Have No Juice As The 2-Year Rate Plunges On November 28, 2023

high mountain pass with winding roads and panoramic vistas.

Stocks Have No Juice As The 2-Year Rate Plunges On November 28, 2023

Subscribe to The Free Market Chronicle and join the 2,750 subscribers getting it for FREE!

11/28/23

#Stocks – $UNH

#Macro – $SPX, #rates, #curve

Mike’s Reading The Markets Macro Subscription Service on Seeking Alpha

Some Recent Titles:

It was another pretty slow day on Tuesday, with most of the action in the bond market, with the 2-year falling by 15 bps, resulting in the yield curve steepening with the 2/10 spread rising by around eight bps to -42 bps. It looks like the move lower in the 2-year started around 8 am, which was when the German preliminary CPI reading for November came in below estimates, falling by -0.1% m/m vs. last month’s flat reading, while year-over-year CPI rose by 3.5% versus October’s 3.8%. The harmonized CPI for Germany for November fell -0.5% versus -0.2% in October while coming in at 2.5% y/y from 3.0% y/y in October.

Those were some pretty big drops in inflation for Germany, and it sent the German 2-year-yield down seven bps on the day, which helped push the US 2-year down. The US 2-Year took another step down around 10:35 am ET when Chris Waller noted that the Fed could cut rates some next year if inflation rates in the US keep coming down. This would seem like common sense, given that if inflation rates come down and the Fed Funds rate doesn’t go down, monetary policy would grow more restrictive, as real rates go higher. So, one would expect the Fed to cut as inflation comes down. Of course, the question is how much inflation comes down and how much the Fed cuts.

If the curve continues to steepen, stocks are likely to sell off. The curve has been driving stocks for a while now, and while stocks did not sell off today, a steepening yield curve will make it very hard for stocks to rally.

United Health (UNH)

Meanwhile, United Health updated its 2024 earnings outlook today; the guidance may have come in a bit mixed, with adjusted earnings at the mid-point of $25.75 versus estimates of $27.83. Meanwhile, revenue guidance came in at $401.50 billion versus estimates for $394.97 billion. Operating cash flow is expected to be $30.50 billion, less than analyst estimates of $31.5 billion. This stock is trading down about 50 bps after hours; it’s not a big deal. But this will be one to watch tomorrow, considering it has the largest weighting in the Dow Jones Industrial Average at 10%. The stock has been trading sideways and is now at the upper end of the range, so a move lower in UNH would probably indicate the Dow moves lower.

-Mike

Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.